Product Liability Archive » November, 2012

Product Liability - November, 2012

263 articles

• Ranbaxy Halts Production Of Generic Lipitor
• Insulation Co. Demands Asbestos Coverage From PMA
• 7th Circ. Lets CBS Fight Asbestos Claims In Federal Court
• Colo. Enviro Firm Seeks Chevron Suit Coverage In 10th Circ.
• Sunshine Rule For Physician Payments Moves Forward
• Washer-Mold Class Asks Justices To Deny Whirlpool Cert. Bid
• Supreme Court Takes Up Appeal Of Post-Mensing Ruling
• Nalco Skirts Lawsuits Over Corexit Use After BP Oil Spill
• Law360 MVP Awards Go To Legal Top Guns From 52 Firms
• Firm Broke Agreement Over GSK Denture Deal: Kline & Specter
• Sen. Skeptical Of Hyundai, Kia Fuel Payback Program
• Lenders, Others Appeal WR Grace Reorganization Plan
• Chevron Disputes Canadian Jurisdiction In $19B Oil Spill Row
• 8th Circ. Reverses $1.1M Levaquin Punitive Damages Award
• Derailed Conrail Tanker Spills Hazardous Vinyl Chloride
• Ex-Takeda Contractor Says New Evidence Revives $6B FCA Suit
• Cosmetics Under Fire: Tips To Avoid FDA Scrutiny
• Highlights Of The New EU Framework For Medical Devices
• 2nd Circ. Eyes Barred Evidence In Yankees Pitcher's Fatal Crash
• Bridgestone, BMW Skid Out Of Defective Tire Action
• AstraZeneca Opposes MDL In Nexium Bone Density Suits
• Venable Adds Commercial Litigation Pro From DLA Piper
• FDA Urged To Give Troubled Compounders A 2nd Look
• 2nd Circ. Backs Another Lilly Win In Zyprexa Warning MDL
• GSK Hit With Suit Over Avodart's Prostate Cancer Risks
• 11th Circ. Reinstates Suit Alleging Hair Bleach Caused Burns
• French Court Nixes Continental's Manslaughter Conviction
• NY High Court Says Inspectors Not Liable In Deadly Capsizing
• How Healthy Is Your Law Firm? Time For A Stress Test
• BP Suspension Shows No Contractor Is Too Big To Debar
• Labeling Changes, Not Ban, On Horizon For Energy Drinks
• SC Builder Coverage Law Lives On, But Insurers Get Reprieve
• 9th Circ. Won't Rehear Alaskans' Climate Change Suit
• Sidley Austin Nabs Seasoned Ex-FDA Counsel
• BP Workers Plead Not Guilty To Manslaughter In Gulf Spill
• NECC Fails To Win Stay In Mass. Meningitis Suits
• NY's Handgun License Law Is Constitutional, 2nd Circ. Says
• Fla. Court Cuts $16.2M From Philip Morris Engle Award
• WTC Developers Must Establish Damages In 9/11 Insurance Row
• Mensing Bars Generic Reglan Suits, Drug Cos. Tell Pa. Court
• Stryker, Howmedica To Face Renewed Implant Defect Suit
• Sears Asks For En Banc Review Of Faulty Washer Class Cert.
• Texas Judge Tosses $12M Malpractice Suit Over ConAgra MDL
• Arizona Beverages 'All Natural' Fraud Class Certified
• BP Suspended From US Contracts After $4.5B Deepwater Deal
• BP Settlement: Lessons About Congressional Investigations
• Builders V. Dragas — An Important Reminder For Insurers
• Bloomberg Risks Public Opinion With Soda Limits, Atty Says
• Sunland Suspension Shows FDA On Hunt For Serial Violators
• Texas Lawmaker Proposes BPA Ban For Children's Products
• Tobacco Cos. Must Admit Deception Over Smoking Hazards
• FDA Reviews Energy Drink Safety After Death Reports
• NJ High Court Mulls Engineer Liability In Defect Suit
• Judge Combines Suits Over Aurora Theater Shooting
• Continental Can't Escape Goldman Construction Accident Suit
• Recklessness Must Be Pled As Defect Defense: Pa. High Court
• How Rigorous Is The 'Rigorous Analysis' Requirement?
• FDA Floats State Enforcement Of New Compounder Standards
• O'Quinn Law Firm Seeks Lexington Docs In Coverage Fight
• Medtronic Says Off-Label Marketing FCA Claims Fall Short
• General Mills Says 'All Natural' False Ad Suit Lacks Merit
• ViewSonic Concealed Computer Monitor Defects, Suit Says
• Which Restatement Of Torts Applies In Pa.?
• Top Dems Seek Answers On Black Elk Oil Rig Explosion
• CPSC To Issue Study Linking Bed Rails To 150 Adult Deaths
• Judge To Review Weinberg Docs In Chevron Enviro Case
• FDA Says Guidelines On Device Review, Recalls Are Priorities
• Energizer Boosts Canada Sunscreen Recall Over Skin Fire Risk
• DC Circ. Blocks CVS Challenge To DEA License Suspensions
• Valero, Sunoco Sued Over Worker's Benzene Exposure
• New Canadian Food Safety Law Boosts Fines, Import Oversight
• Consumers Challenge PVC Deck Cos. Over Durability Claims
• Wal-Mart, Panasonic Accused Of Selling Shoddy Plasma TVs
• Rubio's, Nationwide End Tainted Fish Suit Coverage Fight
• Supreme Court Won't Hear Tobacco Cos.' Engle Challenge
• Synthetic Marijuana Banned In NJ
• Meat Co. Responsible For E. Coli Outbreak, 1st Circ. Says
• As Planet Heats Up, So Does National Security Risk
• Chrysler Wants $25M Faulty Fuel Tank Suit Junked
• Regulators Hammer Black Elk Over Offshore Safety Violations
• Judge Won't Subject All Fosamax MDL Claims To Lone Pine
• FDA Report Faults St. Jude For Handling Of Heart Device
• Pfizer Calls Out Kaiser Over Contradictory Neurontin Claims
• FDA's Push For Compounding Oversight Meets Skepticism
• Investors Say Pfizer Destroyed Files On Celebrex, Bextra
• Eisai Says Zurich Policy Covers Off-Label FCA Suit
• Early Driverless-Car Laws Foretell Rocky Road Ahead
• 2nd Circ. Backs Lilly Win In Drug Label Warning MDL
• Texas Judge Upholds $12M Asarco Asbestos Deal Challenge
• United Airlines Escapes WTC 9/11 Damage Dispute
• Salmonella Fears Spark UK Recall Of Peanut-Based US Imports
• Texas Instruments To Pay $15M Over Radioactive Pollution
• Grappling With The Scope Of Pollution Exclusion
• Foam Makers Targeted Over Allegedly Toxic Insulation
• Judge Gives Tentative OK To 7 Deals In Hot Fuel MDL
• Calif. Court Exposes Hole In 9th Circ. Food Labeling Ruling
• Pa. Appeals Court Rejects New Trial In Asbestos Case
• Judge Exits $1.2B 'Pink Slime' Defamation Case
• NECC Ducks Asset Restriction Bid In Meningitis Case For Now
• High Court To Mull Attys' Fees For Time-Barred Vaccine Claims
• US Steel Sues Pa. Steamfitter For $7M Over Explosion
• Chevron Says NY Pol Favored Ecuadoreans In $19B Enviro Row
• TVA Coal Ash Disaster Damages Row Sent To Mediation
• Australia Blocks Honduran Bid For WTO Panel In Tobacco Row
• NYC Condo Owners Seek $35M Over Sandy Displacement
• US Owes Assistance In Toxic Exposure Suits, KBR Says
• A Closer Look At Dietary Supplement Labels
• Strategic Use Of Lone Pine Motions
• Ford Sues Insurer Over $20M in Product Liability Claims
• Gourmet Grocer Demands Continental Cover Burn Claims
• Hartford Archdiocese Sues For Coverage of Sex Abuse Claims
• FDA Gets No Compounder Oversight Without Doc Release: GOP
• Nelson Mullins Swipes 16 From Cetrulo & Capone In Boston
• 11th Circ. Asks Ga. High Court What Triggers Builder's Policy
• Objectors In $80M Chinese Drywall Deal Want Attys Sanctioned
• Anadarko Shareholders Urge Court Not To Toss Deepwater Suit
• Kawasaki Bike Odometer Class Action Gets Boot
• Challenging CPSC's Database: A Victory For Companies
• NFL Disability Board Undermines League In Concussion MDL
• 9th Circ. Nixes $9.4M Mesothelioma Award Over Expert
• Slaughterhouse Owners Hit With $500M Judgment In FCA Case
• 17 Carriers Owe Asbestos Coverage To Pump Cos., Jury Finds
• Investors Opt Out Of Pfizer Securities Fraud Class Action
• O'Quinn Law Firm Wants Ironshore Silica Coverage Suit Axed
• 6 Risperdal Suits To See Appeal Over Marketers' Dismissal
• Food, Pharma Recalls Jump In 3rd Quarter Of 2012
• Chevron Tells 6th Circ. To Uphold Opposing Counsel Sanctions
• Mid-Century Can't Recoup DR Horton Coverage Row Costs
• Insurer Can't Pull Coverage For Sorenson Shoulder Pump Suits
• KidCo Recalls 220,000 Infant Travel Beds Following Death
• Relators Face Difficulty Pursuing Safety-Based FCA Suits
• Dirty Laundry In 7th Circ.: Recent Class Cert. Cases
• Did The Supreme Court Mean What It Said In Concepcion?
• Suit Pared In Row Over ConAgra's 'Natural' Wesson Claims
• Mutual Makes Last Plea To High Court For Post-Mensing Case
• Senate Slows Down Controversial Cost-Benefit Analysis Bill
• Sens. Demand FDA Meeting Following 5-Hour Death Reports
• Pfizer Ducks FCA Suit Over Lipitor Marketing Practices
• Compounders Fault FDA For Deadly Meningitis Outbreak
• NFL Punter Sues Reliant Stadium Operators Over Knee Injury
• FDA Approved Possibly Harmful Generic Acetadote, Suit Says
• Dobbs V. Wyeth: Are We There Yet, And At What Cost?
• GSK Pays $90M To Settle States' Claims Over Avandia Risks
• FDA Links Sunland Facility Flaws To Salmonella Outbreak
• BP To Pay $4.5B, Cop To Worker Deaths In Deepwater Spill
• Ruling Puts Drug Cos. In Prime Position To Avert State Court
• Judge Won't Revive Class Action Over LG LCD TVs
• Toyota Recalls 2.7M Vehicles Over Steering, Pump Issues
• What To Expect From Fungal Meningitis Liability Cases
• DR Horton Can't Double Travelers Damages In Coverage Row
• NTSB Highlights Top Transport, Infrastructure Safety Issues
• FDA Wants Strong Authority Over 'Nontraditional' Compounders
• Ex-BP Engineer Wants Gov't Emails In Deepwater Texting Case
• High Court May Close Class Waiver Loophole In AmEx Case
• FDA Marketing Rules Stretch To Drugmakers' Media Pitches
• Daimler Triumphs In Suit Over Mercedes Engine Defect
• FDA To Seek More Power Over Compounders At Hearing
• Toyota To Pay $25M To End Investor Suit Over Brake Defects
• Toyota Can't Exclude Rebuttal Reports In Acceleration MDL
• Downstream Plant Found Liable For $3M Paper Mill Damage
• USDA Implements Regular Testing For Organic Food
• Introducing A Plaintiff's Improper Conduct In Va.
• Long Island Utility Faces Class Action Over Sandy Response
• 7th Circ. Backs Class Cert. In Sears Moldy Washer Row
• General Seeks To End Asbestos Claims Coverage For Insulator
• Travelers Still On Hook For Defense Costs In Asbestos Suits
• Pfizer Pays $67.5M To End Investors' Pristiq Disclosure Row
• Tips For Quality Control In Technology-Assisted Review
• Chevron Calls On Argentine Judge To Undo Asset Freeze
• USDA Pulls Plug On Produce Safety Program
• Jury Sides With Seat Belt Maker In Personal Injury Case
• Hensel Phelps Seeks To Exit $2M Airport Train Suit
• Insurer Can't Avoid Covering $8M Pipeline Defect Settlement
• Baxter Recalls Buretrol IV Products Over Air Leakage Risk
• Insurer Off The Hook For $1M Anheuser-Busch Asbestos Deal
• 2nd Homeowners Can Bring Implied Warranty Claims: Pa. Court
• FDA Panel Backs Novo Diabetes Drugs, With Conditions
• Arnold & Porter Adds Life Sciences Pro From Biopharma Firm
• Calif. Homeowner Asks 8th Circ. To Nix Cert. In Uponor MDL
• 750K Jeeps In US Recalled Over Sudden Airbag Deployments
• Broad View Of GARA Opens Doors For Aircraft Manufacturers
• Enviros Lose NRC Hearing Bid On San Onofre Plant Restarts
• The Case For Compounding Pharmacy
• Boeing Blamed for Crash of Russian Superjet in Indonesia
• Judge Won't Let Ex-BP Engineer Off Hook In Deepwater Case
• Calif. Ruling Makes Carcinogen Label A More Inviting Target
• Calif. Voters Shoot Down Soda Tax Ballot Measures
• Nestle Pulls Chocolate Nesquik Mix Over Salmonella Fears
• Nestle Waters Resolves Fire Coverage Fight
• Medical Device Makers Urge FDA To Narrow ID Rule
• Pfizer, Wyeth Lose 3rd Circ. Bid To Toss Pa. Fen-Phen Suit
• Product Group Asks 11th Circ. To Reboot Kawasaki Jet Ski Suit
• Bayer Healthcare Hit With More Mirena Product Defect Suits
• Daimler Wants Out Of Mercedes Gas Leak Class Action
• Obama's Re-Election Will Have Long-Term Effect On CPSC
• Missing The Class Action Removal Boat To Federal Court
• Prop 37 Loss Weakens Push For 'Genetically Engineered' Labels
• Passengers Target Boeing Over Warsaw Crash Landing
• NJ High Court Won't Disturb Novartis Bone Drug Win
• Argentine Judge Freezes Chevron Assets In $19B Judgment Row
• Ties To Polluter Leave Union Carbide Liable, 2nd Circ. Told
• Mass. Official Fired For Ignoring Compounding Center Concerns
• Monster Puts Dangerous Extract In Energy Drink, Suit Says
• Maclaren Wins Suit Claiming Ace Policy Was Wrongly Scrapped
• FDA Won't Pull Pfizer Alzheimer's Drug From Market
• In Context To Chandler V. Cape: Parent Co.'s Duty Of Care
• 11th Circ. Nixes Colleges' Challenge Of Celotex Asbestos Deal
• CPSC Finalizes Safety Standards For Baby Swings
• Qualitest Beats Class Cert. Bid In Birth Control Recall Suit
• FDA Tells DC Circ. It Can't Review Execution Drug Ban
• Window Company Loses Bid To Shutter Defect Suit
• 2nd Circ. Doubtful On Nixing NYC Flavored Tobacco Ban
• Fiberon Beats Claims In Defective Decking Suit
• Dexatrim Maker Beats Suit Alleging Pills Are Unsafe
• New RAPEX Rules — A Boon For EU Product Regulators
• Britax Recalls Child Seat Restraints Due To Choking Hazard
• Pharmacy Owner Subpoenaed To Testify On Meningitis Outbreak
• Class Action Over Maibec Shingle Defects Trimmed
• Novo's Proposed Insulin Drugs Could Pose Risks, FDA Says
• Spotlight On Cost-Shifting Of E-Discovery
• FDA Says Co. Is Trying To Cash In On Meningitis Outbreak
• Obama Win Promises Heightened Push For Product Safety
• Insurer Can't Add Towing Cos. To RV Fridge Fire Suit
• FDA Head To Talk Compounder Oversight In Meningitis Hearing
• MLB Indians Ask 6th Circ. To Revive Fatality Coverage Dispute
• Buckyballs Co. Stops Making Magnet Sets, Citing CPSC Pressure
• Novartis Smacked With $10.5M Verdict In Jaw Injury Suit
• Novartis Bone Drug Appeal Won't Get High Court Review
• 4th Circ. Lets Louisiana-Pacific Dodge Shoddy Home-Trim Suit
• Hydroxycut Consumers Reach $25M Deal In False Ad MDL
• Atty Must Provide $40M Fen-Phen Deal Info To US: 6th Circ.
• National Guardsmen Win $85M In KBR Toxin Suit
• Top 9 Questions About Prop 37
• Pfizer Reports $491M Deal With DOJ Over Rapamune Marketing
• Markey's Post-Outbreak Bill May Fall Short Of Desired Overhaul
• German Shipping Cos. Pay $1.2M For Oil Dumping At Sea
• High Court Asked To Reject Appeal Of Post-Mensing Ruling
• J&J Wins Bid To Keep Children's Tylenol Suit In Fed. Court
• Oyster Fisheries Opt Out Of $8B BP Oil Spill Settlement
• Asbestos Committee Can Join Garlock Personal Injury Case
• Insurers Can't Duck JWR's Chinese Drywall Suit Coverage
• Gulf Landowners Sue BP As Opt-Out Cases Trickle In
• Fed. Circ. Says Woman Didn't Show Vaccine Caused Injury
• NRC Questions Exelon Nuke Plant's Flood Plan Post-Fukushima
• UniQure's Glybera 1st Gene Therapy Approved In EU
• San Francisco Pushes Monster For Proof Of Beverages' Safety
• FTC's Final Green Guides Offer Clarity And Confusion
• Marriott Sued Over Another Death Linked To Legionnaires'
• NH Hospital Must Hand Over Hep C Outbreak Docs To State
• China Pacific Must Defend Whirlpool Over Deadly AC Fire
• Merck Puts Up $39M To Settle Vioxx Class Action
• Takeda Escapes FCA Suit Over Undisclosed Drug Complications
• Markey Rolls Out Reform Bill In Wake Of Meningitis Outbreak
• Tobacco Cos. Ask High Court to Review Graphic Label Ruling
• Insurers Avoid Defending Enviro Firm In Chevron's RICO Suit
• Only Proven Carcinogens Will Make Prop 65 List: Calif. Court
• Va. High Court Says Pollution Exclusion Bars Drywall Coverage
• J&J Close To Settlement With 845 Plaintiffs In Levaquin MDL
• Top Medical Journal Demands More Trial Data From Drug Cos.
• Ecuadoreans Open New Fronts In Chase Of $19B Chevron Award
• Comcast Gives Justices Chance To Raise Class Cert. Bar Again
• Ex-Obama Atty Perrelli Rejoins Jenner & Block In Washington
• Mapping The Pre-Election Landscape